Delivery Order SPE2DB20D1100-SPE2DB25FE1HF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $4,328.80 and an ultimate completion date of August 8, 2025. This award represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Jardiance 10 mg tablets in a 90-day quantity. The contract is a firm fixed-price delivery order with a ceiling value of $22,758.06 and an ultimate completion date of September 15, 2025. This award was competitively awarded with no set-aside designation and represents a child order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency on August 26, 2025, for a supply of Jardiance 10 mg tablets (90-count). The contract carries a ceiling value of $11,245.36 under firm fixed-price terms, with an ultimate completion date of August 27, 2025. This award was issued under a non-set-aside procurement, reflecting open competition. The place of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,871.96. The order is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency for 30 tablets of Jardiance 10 mg, with a ceiling value of $10,510.63 and an ultimate completion date of September 15, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 19, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract value of $2,935.98. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-competitive, non-set-aside award. The delivery will be fulfilled at the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $4,881.13 firm fixed-price delivery order from the Defense Logistics Agency on August 11, 2025, for Jardiance 25 mg tablets (90-count supply). The contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1HFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $26,000.06. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis, consistent with AmerisourceBergen's established procurement relationship with the Defense Logistics Agency for pharmaceutical supply chain support. This delivery order supports the federal military healthcare supply chain by providing Jardiance, a diabetes medication commonly prescribed within Department of Defense medical systems. AmerisourceBergen's comprehensive global pharmaceutical prime vendor contract with DLA enables the distribution of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The company's competitive award record demonstrates its capability to meet federal procurement requirements for essential pharmaceutical commodities at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 9/26/25 |